Skip to main content

Table 2 Univariate Cox regression model adjusted for possible predictors estimating cancer-specific and overall survival in 244 patients treated with cyto-reductive nephrectomy for metastatic renal cell carcinoma

From: Preoperative cholesterol level as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with cyto-reductive nephrectomy

 

Cancer-specific survival

Overall survival

HR

95% CI of HR

p value

HR

95% CI of HR

p value

Age

1.004

0.986–1.023

0.679

1.005

0.989–1.023

0.530

BMI (kg/m 2)

Reference (< 20)

Reference (< 20)

 20–25

0.778

0.456–1.327

0.356

0.783

0.478–1.283

0.332

  ≥ 25

0.373

0.182–0.762

0.007

0.387

0.202–0.743

0.004

Albumin (g/dL)

Reference (< 3.5)

Reference (< 3.5)

 3.5–4.3

0.610

0.375–0.991

0.046

0.577

0.371–0.899

0.015

  ≥ 4.3

0.515

0.290–0.916

0.024

0.485

0.286–0.822

0.007

Heng’s criteria

Reference (Low risk)

Reference (Low risk)

 Intermediate risk

1.265

0.729–2.198

0.403

1.188

0.720–1.961

0.499

 High risk

1.842

0.957–3.546

0.067

1.806

0.999–3.266

0.050

 Cholesterol level (cat.)

2.251

1.285–3.941

0.005

2.100

1.272–3.466

0.004

  1. HR hazard ratio, CI confidence interval, BMI body mass index, cat. Categorical variable
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us